OR WAIT null SECS
- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Evonetix Relocates to New Facility in Cambridge, UK
The new facility is 15,000 ft2, which includes 8000 ft2 of lab space and 7000 ft2 of office space.
Evonetix, a synthetic biology company previously located in Chesterford Research Park, United Kingdom, announced it relocated to a new facility in Coldham’s Business Park, Cambridge, UK on Oct. 30, 2019.
The new facility is 15,000 ft2, which includes 8000 ft2 of lab space and 7000 ft2 of office space, the company said in a press release. The company currently houses 40 employees and will look to recruit further staff to join its teams of physicists, electronics and software engineers, chemists, biologists, and molecular biologists at its new location.
“Synthetic biology has the potential to solve some of the world’s most intractable problems, but we require innovation in gene synthesis to accelerate progress,” said Dr. Tim Brears, Evonetix CEO, in the press release. “Our new office and lab space will enable integration of our teams of specialists to support the development and delivery of our highly parallel desktop platform, which will be available to every researcher to accelerate their ability to use biology on a scale not currently possible.”
